UC-MSCs could inhibit T cell proliferation in lupus patients by secreting large amounts of indoleamine 2,3-dioxygenase (IDO), which is enhanced by IFN-γ produced by CD8+T cells [6]. Here, CD8A is linked to systemic lupus erythematosus.